Evidence map›Paper›PMID 32466490›Full record

ArticleVaccines2020

Severe Multiorgan Failure Following Yellow Fever Vaccination.

Cristina Domingo, Judith Lamerz, Daniel Cadar, Marija Stojkovic, Philip Eisermann, Uta Merle, Andreas Nitsche, Paul Schnitzler

Open access · goldAbstract readCase Reports
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. A Systematic Review on Yellow Fever Vaccine and Adverse Events.Global health, epidemiology and genomics · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cristina DomingoRobert Koch Institute, Centre for Biological Threats and Special Pathogens, 13353 Berlin, Germany.
Judith LamerzDepartment of Internal Medicine IV, University Hospital of Heidelberg, 69120 Heidelberg, Germany.
Daniel CadarBernhard Nocht Institute for Tropical Medicine, National Reference Centre for Tropical Pathogens, 20359 Hamburg, Germany.
Marija StojkovicCenter for Infectious Diseases, Tropical Medicine, University Hospital of Heidelberg, 69120 Heidelberg, Germany.
Philip EisermannBernhard Nocht Institute for Tropical Medicine, National Reference Centre for Tropical Pathogens, 20359 Hamburg, Germany.
Uta MerleDepartment of Internal Medicine IV, University Hospital of Heidelberg, 69120 Heidelberg, Germany.
Andreas NitscheRobert Koch Institute, Centre for Biological Threats and Special Pathogens, 13353 Berlin, Germany.
Paul SchnitzlerCenter for Infectious Diseases, Virology, University Hospital of Heidelberg, 69120 Heidelberg, Germany.
Heidelberg University · DEBernhard Nocht Institute for Tropical Medicine · DERobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe yellow fever (YF) vaccination is recommended by the WHO for people traveling or living in endemic areas at risk for yellow fever infections in Africa and South America. Although the live attenuated yellow fever vaccine is a safe and efficient vaccine, rare serious adverse events after vaccination have been reported. CASE PRESENTATION: We present the case of a 74-year-old male with multiorgan failure after yellow fever vaccination for a trip to Brazil. The patient required admission to the intensive care unit with a prolonged stay due to severe organ dysfunction. Five days after the YF vaccination, the patient experienced nausea, vomiting, diarrhea, and general illness. Three days later he sought medical attention and was transferred to the University Hospital Heidelberg with beginning multiorgan failure and severe septic shock, including hypotonia, tachypnea, thrombopenia, and acute renal failure the same day. Within one week after vaccination, antibodies against YF virus were already detectable and progressively increased over the next two weeks. Viral RNA was detected in serum on the day of admission, with a viral load of 1.0 × 10

conclusionsThe risk for severe adverse events due to the YF vaccination should be balanced against the risk of acquiring a severe YF infection, especially in elderly travelers.

Indexed as

multiorgan failurevaccinationviscerotropic diseaseyellow fever virus

Identifiers

PMID32466490
PMCPMC7349955
OpenAlexW3030907852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.